BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27365493)

  • 21. Multilocus genetic risk scores for coronary heart disease prediction.
    Ganna A; Magnusson PK; Pedersen NL; de Faire U; Reilly M; Arnlöv J; Sundström J; Hamsten A; Ingelsson E
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2267-72. PubMed ID: 23685553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies.
    Brautbar A; Pompeii LA; Dehghan A; Ngwa JS; Nambi V; Virani SS; Rivadeneira F; Uitterlinden AG; Hofman A; Witteman JC; Pencina MJ; Folsom AR; Cupples LA; Ballantyne CM; Boerwinkle E
    Atherosclerosis; 2012 Aug; 223(2):421-6. PubMed ID: 22789513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations from the EGAPP Working Group: genomic profiling to assess cardiovascular risk to improve cardiovascular health.
    Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
    Genet Med; 2010 Dec; 12(12):839-43. PubMed ID: 21042222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of a cardiovascular disease genetic risk score in the Diabetes Heart Study.
    Raffield LM; Cox AJ; Carr JJ; Freedman BI; Hicks PJ; Langefeld CD; Hsu FC; Bowden DW
    Acta Diabetol; 2015 Aug; 52(4):743-51. PubMed ID: 25700702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
    de La Harpe R; Thorball CW; Redin C; Fournier S; Müller O; Strambo D; Michel P; Vollenweider P; Marques-Vidal P; Fellay J; Vaucher J
    Eur J Prev Cardiol; 2023 May; 30(7):561-571. PubMed ID: 36652418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
    Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
    Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of genetic information for diabetes risk prediction - differences according to sex, age, family history and obesity.
    Mühlenbruch K; Jeppesen C; Joost HG; Boeing H; Schulze MB
    PLoS One; 2013; 8(5):e64307. PubMed ID: 23700469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Incremental Value of a Coronary Artery Calcium Score Beyond Traditional Cardiovascular Risk Assessment: A Systematic Review and Meta-analysis.
    Bell KJL; White S; Hassan O; Zhu L; Scott AM; Clark J; Glasziou P
    JAMA Intern Med; 2022 Jun; 182(6):634-642. PubMed ID: 35467692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study.
    Willeit P; Kiechl S; Kronenberg F; Witztum JL; Santer P; Mayr M; Xu Q; Mayr A; Willeit J; Tsimikas S
    J Am Coll Cardiol; 2014 Sep; 64(9):851-60. PubMed ID: 25169167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
    Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
    Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study.
    Perrot N; Verbeek R; Sandhu M; Boekholdt SM; Hovingh GK; Wareham NJ; Khaw KT; Arsenault BJ
    Atherosclerosis; 2017 Jan; 256():47-52. PubMed ID: 27998826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive improvement of adding coronary calcium score and a genetic risk score to a traditional risk model for cardiovascular event prediction.
    Temtem M; Mendonça MI; Gomes Serrão M; Santos M; Sá D; Sousa F; Soares C; Rodrigues R; Henriques E; Freitas S; Borges S; Rodrigues M; Guerra G; Drumond Freitas A; Sousa AC; Palma Dos Reis R
    Eur J Prev Cardiol; 2024 Apr; 31(6):709-715. PubMed ID: 38175668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic risk prediction and a 2-stage risk screening strategy for coronary heart disease.
    Tikkanen E; Havulinna AS; Palotie A; Salomaa V; Ripatti S
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2261-6. PubMed ID: 23599444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
    Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
    Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III.
    Zalawadiya SK; Veeranna V; Mallikethi-Reddy S; Bavishi C; Lunagaria A; Kottam A; Afonso L
    Eur J Prev Cardiol; 2015 Apr; 22(4):513-8. PubMed ID: 24431384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The REGICOR study.
    Velescu A; Clara A; Peñafiel J; Ramos R; Marti R; Grau M; Dégano IR; Marrugat J; Elosua R;
    Atherosclerosis; 2015 Aug; 241(2):357-63. PubMed ID: 26071658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals.
    Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ
    Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grip Strength and Walking Pace and Cardiovascular Disease Risk Prediction in 406,834 UK Biobank Participants.
    Welsh CE; Celis-Morales CA; Ho FK; Brown R; Mackay DF; Lyall DM; Anderson JJ; Pell JP; Gill JMR; Sattar N; Welsh P; Gray SR
    Mayo Clin Proc; 2020 May; 95(5):879-888. PubMed ID: 32299669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
    Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
    Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.